JORDAN SCOTT (Chief Financial Officer) purchased 55.6% of their position (11.30K shares) of DECOY THERAPEUTICS INC. on the open market
Open‑market purchase worth $10.2K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/18/2020ACC: 0001615219-20-000003
Officer· Chief Financial Officer
Since Jul 2019
+11.30K
Net shares
Net buyer
$10.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
11.30K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+11.30K
Price / share
$0.90
Trade value
$10.17K
% of position
55.6%
2/18/2020
20.31K→31.61K
Total
Net shares
+11.30K
Net value
$10.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/18/2020 | P · Purchase | +11.30K | $0.90 | $10.17K | 55.6% | 20.31K | 31.61K |
| Total | +11.30K | $10.17K | ||||||
Derivative Transactions0
No derivative transactions reported